Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocrystal Gels for Peri-implant Mucositis
NCT06915623Phase 1Completed
- Start
- Jun 2023
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in peri-implant mucositis (2 arms). Primary endpoint: Bleeding on Probing at 4 weeks. Started Jun 2023; status: completed.
02
Conditions
peri-implant mucositis
Beyond the preview
Go deeper on NCT06915623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06915623.